NCT06495736 Application of Rapid On-site Evaluation in Lymph Node Biopsy of Breast Cancer
| NCT ID | NCT06495736 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yunnan Cancer Hospital |
| Condition | Breast Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 400 participants |
| Start Date | 2024-02-01 |
| Primary Completion | 2026-02 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 400 participants in total. It began in 2024-02-01 with a primary completion date of 2026-02.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to evaluate the value of rapid on-site evaluation（ROSE） in lymph node biopsy of breast cancer. The main question it aims to answer is:The ROSE technique was applied to breast cancer lymph node biopsy to improve the diagnostic efficiency and accuracy. Participants underwent routine lymph node biopsy, and the test personnel conducted routine disease examination and rose technique evaluation on the removed ly
Eligibility Criteria
Inclusion Criteria: * Patients had pathologically confirmed primary breast cancer * Surgical treatment was available Exclusion Criteria: * Previous history of surgery on the affected axilla, internal breast or chest * Pregnant or breastfeeding patients * Previous radiotherapy or chemotherapy * Complicated history of other tumors
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06495736 clinical trial?
This trial is open to female participants only, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06495736 currently recruiting?
Yes, NCT06495736 is actively recruiting participants. Contact the research team at tangqi@kmmu.edu.cn for enrollment information.
Where is the NCT06495736 trial being conducted?
This trial is being conducted at Kunming, China.
Who is sponsoring the NCT06495736 clinical trial?
NCT06495736 is sponsored by Yunnan Cancer Hospital. The trial plans to enroll 400 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.